Overview
- 151 inspections across 143 sites are on record.
- 276 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-04-20.
At a glance
Inspections
151
Sites
143
Observations
276
Career since
Dec 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Noveal | 20 Apr 2016 | Human Drugs | |
| ACM Pharma | 15 Apr 2016 | Human Drugs | On file |
| Haupt Pharma Wolfratshausen GmbH | 9 Apr 2016 | Human Drugs | View 483 → |
| Sanofi Winthrop Industrie | 26 Feb 2016 | Human Drugs | On file |
| Wickham Micro Limited | 17 Feb 2016 | Human Drugs | View 483 → |
Sites inspected
NovealMourenx, France1 insp.
ACM PharmaBellegarde, France1 insp.
Haupt Pharma Wolfratshausen GmbHWolfratshausen, Germany1 insp.
Sanofi Winthrop IndustrieAramon, France1 insp.
Wickham Micro LimitedGosport, United Kingdom1 insp.
Co-investigators
Investigators who share inspections with this person.
Meisha R Sampson45 shared
Brittany D Terhar17 shared
Candace S Tucker13 shared
Kathleen J Close9 shared
Collins M Mason5 shared
Andrew J Idzior4 shared
Daniel J Gorski4 shared
Robert M Barbosa4 shared
Erin C Dugan4 shared
Satheesh Thomas3 shared
Full investigator report
Get the verbatim findings behind Meisha R Waters' 276 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site